|Year : 2015 | Volume
| Issue : 4 | Page : 570-573
Surgical re-entry evaluation of regenerative efficacy of bioactive Gengigel™ and platelet-rich fibrin in the treatment of grade II furcation: A novel approach
Gurkirat Kaur Sandhu, Paramjit Kaur Khinda, Amarjit Singh Gill, Harveen Singh Kalra
Department of Periodontology and Oral Implantology, Genesis Institute of Dental Sciences and Research, Ferozepur, Punjab, India
|Date of Web Publication||19-Nov-2015|
Gurkirat Kaur Sandhu
House No. 354, Green Avenue, Amritsar - 143 001, Punjab
Source of Support: None, Conflict of Interest: None
| Abstract|| |
The furcation area creates situations in which routine periodontal procedures are somewhat limited, and surgical procedures are generally required. The introduction of bioactive agents, such as platelet concentrates, enamel matrix derivatives, bone morphogenic proteins, and matrix macromolecules such as hyaluronic acid has expanded the scope for better outcomes in furcation treatment. Hyaluronic acid is a naturally occurring nonsulfated high molecular weight glycosaminoglycan that forms a critical component of the extracellular matrix and contributes significantly to tissue hydrodynamics, cell migration, and proliferation. Platelet-rich fibrin (PRF) is an immune and platelet concentrate containing all the constituents of a blood sample, which are favorable for healing and immunity. The purpose of the present case report was to assess through surgical re-entry, the regenerative capacity of Gengigel™ in conjunction with PRF in a patient with grade II furcation defect. It was observed that the combined approach resulted in significant furcation defect fill on re-evaluation at 6 months.
Keywords: Furcation, Gengigel ®, hyaluronic acid, platelet-rich fibrin
|How to cite this article:|
Sandhu GK, Khinda PK, Gill AS, Kalra HS. Surgical re-entry evaluation of regenerative efficacy of bioactive Gengigel™ and platelet-rich fibrin in the treatment of grade II furcation: A novel approach. Contemp Clin Dent 2015;6:570-3
|How to cite this URL:|
Sandhu GK, Khinda PK, Gill AS, Kalra HS. Surgical re-entry evaluation of regenerative efficacy of bioactive Gengigel™ and platelet-rich fibrin in the treatment of grade II furcation: A novel approach. Contemp Clin Dent [serial online] 2015 [cited 2020 Oct 21];6:570-3. Available from: https://www.contempclindent.org/text.asp?2015/6/4/570/169855
| Introduction|| |
Multi-rooted teeth offer unique and challenging problems for the periodontist. The furcation area creates situations in which routine periodontal procedures, such as scaling and root planing are somewhat limited, and surgical procedures are generally required. Treatment approaches that have been used to resolve grade II furcation defects surgically include autografts, demineralized freeze-dried bone allografts, bovine-derived xenografts, barrier membranes, and combinations of membranes and bone grafts. Even though these regenerative materials are still used today, the introduction of bioactive agents, such as platelet concentrates, enamel matrix derivatives, bone morphogenic proteins, and matrix macromolecules such as hyaluronic acid has expanded the scope for better outcomes in furcation treatment.
Hyaluronic acid (hyaluronan) is a linear, widely distributed glycosaminoglycan of the extracellular matrix of mammalian connective tissues, primarily synthesized by mesenchymal cells and forms the backbone for the organization of proteoglycans, establishing links with collagen, fibrin, and different matrix molecules. Gengigel ® (Ricerfarma, Milano, Italy) contains high molecular weight fractions of Hyaluronic acid in gel formulation with 0.8% concentration suitable for bone regeneration in periodontal bony defects [Figure 1]a. Gengigel as a product for oral use has been evaluated by skin irritation test, sensitizing potentiality, and percutaneous absorption test and has been proved to be a safe nonirritant product.
|Figure 1: (a) Gengigel® (0.8% Hyaluronic acid, Ricerfarma, Milano, Italy). (b) Miller's Class I gingival recession in mandibular left first molar region. (c) Radiovisiographic examination showing radiolucency in the mandibular left first molar furcation area|
Click here to view
Platelet-rich fibrin (PRF) is an immune and platelet concentrate, containing all the constituents of a blood sample which are favorable for healing and immunity. It consists of a fibrin matrix polymerized in a tetra-molecular structure, with the incorporation of platelets, leukocytes, cytokines, circulating stem cells, and growth factors. Hence, the purpose of the present case report was to assess the regenerative capacity of Gengigel ® in conjunction with bioactive PRF in a patient with grade II furcation defect.
| Case Report|| |
A 40-year-old male patient reported to the outpatient Department of Periodontics with a chief complaint of bleeding gums while brushing and sensitivity to cold while eating and drinking in the lower back tooth region. Clinical examination revealed Miller's Class I gingival recession and grade II furcation involvement in the mandibular left first molar region and [Figure 1]b. On radiovisiographic examination of the region, radiolucency was noted in the furcation area [Figure 1]c. Treatment was accomplished through Phase I and Phase II therapy. During Phase I therapy, full-mouth scaling and root planing was done, and general oral hygiene instructions were given. Phase II therapy included open flap debridement, followed by regeneration of the furcation defect. Following administration of local anesthesia, buccal and lingual crevicular incisions were made, and the mucoperiosteal flap was reflected to access the underlying bone morphology in the furcation area [Figure 2]a. After meticulous debridement with Gracey curettes [Figure 2]b, the furcation area was assessed using Q2N Naber's probe [Figure 2]c. It was found that the assessed defect was around 3 mm horizontally and 2 mm vertically [Figure 2]c.
|Figure 2: (a) Crevicular incision. (b) Exposure of defect site after debridement. (c) Intra-operative furcation defect measurement using Q2N Naber's probe having horizontal dimension ~ 3 mm (grade II furcation). (d) Application of Gengigel® (0.8% Hyaluronic acid) in the defect site|
Click here to view
Then, around 5 ml of whole venous blood was collected from the antecubital vein of the patient in a sterile vacutainer tube without anticoagulant for the preparation of autologous PRF. The vacutainer tube was placed in the centrifugal machine set at 3000 revolutions per minute (rpm) for 10 min. The resultant product consisted of platelet poor plasma at the top, PRF clot in the middle and red blood cells at the bottom. Meanwhile, the debrided defect was slightly overfilled with Gengigel ® (Ricerfarma, Milano, Italy) [Figure 2]d. Autologous PRF of the required size was filled into the furcation defect after separation from the other two layers [Figure 3]a and [Figure 3]b and the remainder part was used as a GTR membrane by squeezing out the fluids to cover the furcation [Figure 3]c. The reflected flap was repositioned over the PRF membrane and secured with interrupted direct loop 3-0 nonresorbable silk sutures. The patient was put on systemic analgesics and antibiotics (500 mg of paracetamol every 6 h and 500 mg of amoxicillin every 8 h for 5 days), along with chlorhexidine digluconate rinses (0.12%) twice daily for 2 weeks. Instructions to continue regular oral hygiene except in the operated area were given. The sutures were removed 1 week after the surgery [Figure 4] and gentle tooth brushing with a soft toothbrush using Charter's method was initiated. Oral hygiene instructions were reinforced.
|Figure 3: (a and b) Placement of Platelet-rich fibrin in the defect site after presuturing. (c) Placement of Platelet-rich fibrin membrane. (d) Six months postoperative furcation defect assessment through surgical re-entry using Q2N Naber's probe showing residual horizontal dimension of <1 mm|
Click here to view
Surgical re-entry was performed after 6 months [Figure 5]. A mini-mucoperiosteal flap was raised after giving crevicular incision. The furcation area was reassessed clinically with the help of Q2N Naber's probe to assess the bone fill [Figure 3]d and [Figure 6]. Healing was uneventful and at 6 months of follow-up, there was substantial defect fill in the furcation area with a residual horizontal dimension of <1 mm at 6 months, representing a significant percentage of bone formation [Figure 3]d, [Figure 6] and [Figure 7].
| Discussion|| |
Hyaluronan provides a structural framework by interacting with the fibrin clot, which facilitates extracellular matrix cell infiltration into the inflamed site. It also induces the production of a series of pro-inflammatory cytokines by fibroblasts, keratinocytes, cementoblasts, and osteoblasts, which promote the inflammatory response. It is further involved in the functional activation of inflammatory cells, such as polymorphonuclear leukocytes and macrophages. During granulation phase, hyaluronan promotes cell proliferation and migration of matrix cells into granulation tissue matrix leading to its organization. In the later stage of the granulation phase, hyaluronan synthesis ceases and existing hyaluronan is depolymerized by hyaluronidases resulting in the formation of lower molecular weight hyaluronan molecules, which promote angiogenesis in the wound site. It also accelerates bone regeneration by chemotaxis, proliferation, and differentiation of mesenchymal cells into osteoblasts and is osteoinductive in nature.
PRF, on the other hand, has been used to fill the defect and the remainder as a GTR membrane after squeezing the fluids to cover the defect. PRF organizes as a dense fibrin scaffold for migration of stem cells and exhibits slow release of growth factors (transforming growth factor-1β, platelet-derived growth factor-AB, vascular endothelial growth factor) and glycoproteins (thrombospondin-1), which modulate the regeneration process, resulting in the formation of new cementum, periodontal ligament, and alveolar bone. The ability to use PRF as a GTR membrane is an added advantage.
To the best of our knowledge, no study was found to use Gengigel ® in conjunction with PRF in the treatment of furcation. The postoperative bone fill was examined through surgical re-entry in this case report, to assess the horizontal component of defect fill after 6 months, and obvious bone formation was noticed. This is in accordance with a study by Ballini et al., who found that autologous bone combined with an esterified low-molecular HA preparation is capable of accelerating new bone formation in the infra-bone defects. Fawzy El-Sayed et al., in a randomized controlled trial evaluated the effect of local application of 0.8% Hyaluronan gel in conjunction with periodontal surgery and noted statistically significant differences in clinical attachment level (P < 0.05) in favor of the test sites though nonsignificant results were obtained regarding probing depth.
Conversely, Kanakamedala et al. have successfully treated a mandibular grade II furcation defect with PRF and bone graft. Bajaj et al. have also demonstrated significantly more grade II furcation closure rates than traditional open flap instrumentation with the use of autologous PRF or PRP. These studies, therefore, support the fact that the combined use of Gengigel ® in conjunction with PRF seems to have an added benefit in the regeneration of Class II furcation, as described in this case report.
The study was supported by our institution and the products used were supplied by Ricerfarma, Italy.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen 1999;7:79-89.
Bansal J, Kedige SD, Anand S. Hyaluronic acid: A promising mediator for periodontal regeneration. Indian J Dent Res 2010;21:575-8.
Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al.
Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e56-60.
Ruggiero SL, Bertolami CN, Bronson RE, Damiani PJ. Hyaluronidase activity of rabbit skin wound granulation tissue fibroblasts. J Dent Res 1987;66:1283-7.
Mendes RM, Silva GA, Lima MF, Calliari MV, Almeida AP, Alves JB, et al.
Sodium hyaluronate accelerates the healing process in tooth sockets of rats. Arch Oral Biol 2008;53:1155-62.
Dohan Ehrenfest DM, de Peppo GM, Doglioli P, Sammartino G. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): A gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009;27:63-9.
Ballini A, Cantore S, Capodiferro S, Grassi FR. Esterified hyaluronic acid and autologous bone in the surgical correction of the infra-bone defects. Int J Med Sci 2009;6:65-71.
Fawzy El-Sayed KM, Dahaba MA, Aboul-Ela S, Darhous MS. Local application of hyaluronan gel in conjunction with periodontal surgery: A randomized controlled trial. Clin Oral Investig 2012;16:1229-36.
Kanakamedala A, Ari G, Sudhakar U, Vijayalakshmi R, Ramakrishnan T, Emmadi P. Treatment of a furcation defect with a combination of platelet-rich fibrin (PRF) and bone graft – A case report. ENDO (Lond Engl) 2009;3:127-35.
Bajaj P, Pradeep AR, Agarwal E, Rao NS, Naik SB, Priyanka N, et al.
Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of mandibular degree II furcation defects: A randomized controlled clinical trial. J Periodontal Res 2013;48:573-81.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7]